Please use this identifier to cite or link to this item:
|Title:||Patient's assessment of discomfort during ultrasound-guided injection of Morton's neuroma: selecting the optimal approach.||Austin Authors:||Yap, Lee Pheng ;McNally, Eugene||Affiliation:||Radiology Department, Austin Health, 145 Studley Road, Heidelberg, Victoria 3084, Australia||Issue Date:||15-May-2012||Publication information:||Journal of Clinical Ultrasound : Jcu 2012; 40(6): 330-4||Abstract:||Assess patient discomfort during two different methods of injection of Morton's neuroma.Sixty-eight patients referred for ultrasound-guided injection of Morton's neuroma had punctures performed dorsal or plantar to the interdigital skin crease, with and without preliminary subcutaneous local anesthesia (LA). Patients rated discomfort during skin puncture (SP) and needle advancement (NA) using a visual analog scale.Average pain score was 4.4 ± 2.3 (1 SD) for the plantar approach and 2.9 ± 2.0 for the dorsal approach. This difference was statistically significant during SP (p < 0.01) and NA (p < 0.05). During the plantar approach with LA, mean pain score during SP was 4.4 (± 2.1) and 3.9 (± 2.8) during NA. This plantar approach without LA resulted in a pain score of 4.3 (± 2.6) and 3.8 (± 3.1), respectively. Mean pain scores for patients injected from the dorsal approach with LA during SP were 3.8 (± 2.7) and NA were 2.2 (± 2.0) and without LA were 2.6 (± 1.9) and 3.0 (± 2.1). There was no statistical significance in mean pain score difference during SP and NA, with and without LA for either the plantar (p > 0.05) or the dorsal (p > 0.05) approach.Injection of Morton's neuroma was better tolerated via a dorsal approach and use of preliminary LA did not confer any benefit.||Gov't Doc #:||22585530||URI:||https://ahro.austin.org.au/austinjspui/handle/1/11489||DOI:||10.1002/jcu.21926||Journal:||Journal of clinical ultrasound : JCU||URL:||https://pubmed.ncbi.nlm.nih.gov/22585530||Type:||Journal Article||Subjects:||Adult
Anesthetics, Local.administration & dosage
Peripheral Nervous System Neoplasms.drug therapy
|Appears in Collections:||Journal articles|
Show full item record
checked on Nov 29, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.